1. Home
  2. PPSI vs SNTI Comparison

PPSI vs SNTI Comparison

Compare PPSI & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pioneer Power Solutions Inc.

PPSI

Pioneer Power Solutions Inc.

HOLD

Current Price

$2.96

Market Cap

33.1M

Sector

Industrials

ML Signal

HOLD

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

HOLD

Current Price

$0.45

Market Cap

31.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PPSI
SNTI
Founded
2008
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.1M
31.5M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
PPSI
SNTI
Price
$2.96
$0.45
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.50
AVG Volume (30 Days)
56.9K
228.0K
Earning Date
04-08-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
77.31
EPS
N/A
N/A
Revenue
$27,627,000.00
N/A
Revenue This Year
$2.71
N/A
Revenue Next Year
$22.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
20.75
N/A
52 Week Low
$2.35
$0.33
52 Week High
$6.29
$2.88

Technical Indicators

Market Signals
Indicator
PPSI
SNTI
Relative Strength Index (RSI) 38.46 42.55
Support Level $2.75 $0.33
Resistance Level $3.36 $1.18
Average True Range (ATR) 0.23 0.04
MACD 0.03 0.03
Stochastic Oscillator 26.00 81.88

Price Performance

Historical Comparison
PPSI
SNTI

About PPSI Pioneer Power Solutions Inc.

Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets. The Company launched two new product platforms namely, PRYMUS, a new, mobile on-site power system concentrating on customers with requirements of 1-10 megawatts of mobile power and PowerCore, a residential and small commercial based primary generator system integrating a DC fast charger into one solution.

About SNTI Senti Biosciences Inc.

Senti Biosciences Holdings Inc, formerly known as Senti Biosciences Inc, is a clinical-stage biotechnology company developing cell and gene therapies using its gene circuit platform for patients with incurable diseases. Its gene circuits, created from proprietary DNA sequences, are designed to reprogram cells to sense, compute, and respond to cellular environments. Its product candidates are to kill cancer cells, spare healthy cells, increase specificity, and control drug expression. Its candidate, SENTI-202, is a logic-gated off-the-shelf CAR-NK cell therapy for blood cancers, currently in a Phase 1 clinical trial in the United States and Australia for relapsed or refractory hematological malignancies, including Acute Myeloid Leukemia (AML).

Share on Social Networks: